Bevacizumab effective for patients with glioblastoma

Bevacizumab (Avastin) based therapy could be used to make a real difference for patients with glioblastoma.
Roche announced that Bevacizumab was found effective during phase II BRAIN study of bevacizumab alone or in combination with irinotecan chemotherapy for treating relapsed or progressive glioblastoma (GBM).
From Medicalnewstoday.com:

“Stabilising neurocognitive function and reducing reliance on steroids can improve [...]

Diabetes-related edema and cataract surgery manageable with cancer treatment

The usage of bevacizumab (Avastin) to offer relief to patients with macular edema and individuals with cystoid macular edema after cataract surgery has been reported by the journal Ophthalmology.
Another study suggested methods to improve the safety level for making cataract surgery safer for diabetic retinopathy (DR) patients.
Diabetic retinopathy is considered to become one of the [...]